Photodynamic therapeutic role of indocyanine green in tumor-associated inflammation in skin cancer
Introduction
Photodynamic therapy (PDT) is increasingly applied as an alternative treatment for superficial cancer. PDT involves photosensitizer (PS) administration followed by an illumination of tumor with light of appropriate wavelength to activate the PS [1]. Activation of PS transforms its ground state (1PS) into an excited singlet state (1PS*). To obtain therapeutic effect, PS must undergo electron spin conversion to its triplet state (3PS*). In the presence of oxygen, the excited molecule can react with a biological substrate (membrane lipids, proteins, nucleic acids, etc.) and form free radicals, which can interact with ground-state molecular oxygen to produce reactive oxygen species (ROS) (type I reaction). Alternatively, the energy of the excited PS can be directly transferred to oxygen to form non-radical but highly reactive singlet oxygen (1O2), which is the most damaging species generated during PDT (type II reaction) [2]. The in situ generation of 1O2 can directly kill tumor cells by the induction of apoptosis and necrosis and can damage the tumor vasculature and the surrounding healthy vessels, resulting in indirect tumor death via the induction of hypoxia and starvation. In addition, PDT is able to initiate an immune response against the remaining tumor cells [3]. The efficacy of PDT in the treatment of cancer depends on the PS type, concentration, intracellular localization, light dose (fluence) and dose rate (fluence rate), oxygen availability, and the treatment regimen given [1].
Skin cancers are ideally suited for PDT. In an early clinical trial, complete response rates of 85% were achieved by the use of the PS hematoporphyrin derivative followed by red light [4]. Since then, several studies confirmed that PDT, using different sensitizers, achieved response rates for superficial skin cancers that are equivalent to those achieved by conventional methods (e.g. cryotherapy and surgical excision). Today three more sensitizers are approved for clinical use; 5-aminolevulinic acid (5-ALA, Levulan®), the methyl ester of ALA (Metvix®, Photocure ASA), and meso-tetra-hydroxyphenyl-chlorin (mTHPC, Foscan®) and PDT is becoming an established treatment modality for localized cancers including non-melanoma skin cancer [5], [6], [7], [8].
Indocyanine green (ICG; 4, 5-benzoindotricarbocyanine; C43H47N2NaO6S2), is a negatively charged water-soluble anionic dye that is commonly used as an angiographic agent. ICG has a strong absorption in the near IR (between 700 and 800 nm), which is an important photochemical property, because it is known that melanins do not significantly absorb in this area [9]. Additionally, near IR light is characterized by a deep penetration into tissue [10]. The fact that ICG absorbs in the near IR region of the spectrum together with the fact that melanins do not absorb in this wavelength area is essential and important for assessing ICG/PDT in skin cancer treatment. In a previous study, ICG was reported to have a promising cytotoxic effect (at concentration 100 μM) on human (Sk-Mel-188) and mouse (S91) melanoma cells, where the surviving fraction of the treated cells decreased more than 10-fold (at 100 J/cm2 with the fluence rate of 200 mW/cm2) compared with non-treated cells [11]. In an early study by our group [12], ICG concentration of 150 μM was selected as a safe effective dose for the treatment of Sk-Mel-28 melanomas cells and the experiment also indicated that at this dose of ICG the laser exposure (wavelength; 788 nm, average power; 400 mW and density; 57 mW/cm2) for 30 min or less led to <20% cell death, while exposure for 60 min resulted in dramatic membrane damage in 71% of the cells, which means that cell viability is both ICG concentration and light dose dependent. Recently a study was performed by our group [13] studying the phototoxic and genotoxic effect of ICG and ICG-entrapped in polymeric nanoparticles on two different cell lines; human breast adenocarcinoma cells (MCF-7) and hepatocellular carcinoma cells (HepG2) using different concentrations of ICG (12.5–200 μM), laser dose (wavelength; 807 nm, average power; 400 mW and power density; 51 mW/cm2), and 20 min time period of exposure. The results revealed that ICG has a good phototoxic effect and this phototoxic effect increased with increasing in the ICG concentration. ICG also showed a DNA damage effect at high concentration on tumor cells [13]. The present study is an in vivo approach to evaluate the efficacy of ICG as an efficient PS agent for skin cancer induced in two-stage murine skin carcinogenesis model.
Section snippets
Materials and methods
All chemicals were purchased from (Sigma/Aldrich, VA, USA) except mentioned. The antibodies used were purchased from (R&D Systems, Minneapolis, MI, USA) or (Abcam Inc., USA).
Histopathological examination
The histological examination of skin tissue sections from the following groups (Normal, Acetone, ICG, Laser and ICG/Laser) showed normal histopathology; uniformly arranged epidermal and dermal layers with normal layer of keratin. However, the examination of tumor sections from (DMBA/TPA) group showed an abnormal thickened epidermis with irregular proliferation and hyperplasia of prickle cell layer (acanthosis) as well as hyperkeratosis (i.e. thickening of keratinized layer) and islands of
Discussion
PDT is a promising noninvasive treatment and a good alternative to cutting surgery or chemotherapy for cancer. The successful clinical use of PDT requires the selection of the most appropriate PS and a suitable PS delivery system and the optimal laser exposure conditions after PS administration [1]. The main interest in using ICG as a PS in PDT comes from the fact that this dye has a strong absorption band in the NIR range, which falls in the “photodynamic window” [24]. In this study we
Conflict of interest statement
The authors declare no conflict of interest.
Acknowledgements
We are grateful to Laser Research Unit team, NRC, Egypt, in particular Prof. Dr. Ali Shabaka for their efforts. This work was financially supported by the National Research Center, Cairo, Egypt.
References (52)
- et al.
Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT
J Photochem Photobiol B
(2009) - et al.
Molecular effectors of multiple cell death pathways initiated by photodynamic therapy
Biochim Biophys Acta
(2007) - et al.
Hematoporphyrin derivative: a possible aid in the diagnosis and therapy of carcinoma of the bladder
J Urol
(1976) - et al.
Nonmelanoma skin cancer of the head and neck: nonsurgical treatment
Facial Plast Surg Clin North Am
(2012) - et al.
Aminolevulinic acid (ALA): photodynamic detection and potential therapeutic applications
J Surg Res
(2013) - et al.
A review of NIR dyes in cancer targeting and imaging
Biomaterials
(2011) - et al.
In vitro efficiency and mechanistic role of indocyanine green as photodynamic therapy agent for human melanoma
Photodiagnosis Photodyn Ther
(2009) - et al.
Photodynamic therapeutic activity of indocyanine green entrapped in polymeric nanoparticles
Photodiagnosis Photodyn Ther
(2013) - et al.
A rapid simple spectrophotometric method for simultaneous detection of nitrate and nitrite
Nitric Oxide: Biol Chem
(2001) - et al.
Tumor regression induced by photodynamic treatment with chlorin p(6) in hamster cheek pouch model of oral carcinogenesis: dependence of mode of tumor cell death on the applied drug dose
Oral Oncol
(2011)
Role of mitochondrial cardiolipin peroxidation in apoptotic photokilling of 5-aminolevulinate-treated tumor cells
Arch Biochem Biophys
Arachidonic acid cascade inhibitors modulate phorbol ester-induced oxidative stress in female ICR mouse skin: differential roles of 5-lipoxygenase and cyclooxygenase-2 in leukocyte infiltration and activation
Free Radic Biol Med
Involvement of tumor necrosis factor (TNF)-(in phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin edema in mice
Biochem Pharmacol
Mutagenicity of nitric oxide and its inhibition by antioxidants
Mutat Res
Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway
Am J Pathol
Photodynamic therapeutic effect of indocyanine green entrapped in polymeric nanoparticles and their anti-EGFR-conjugate in skin cancer in CD1 mice
Photodiagnosis Photodyn Ther
Cyclooxygenases in cancer: progress and perspective
Cancer Lett
Up-regulation of cyclooxygenase-2 and apoptosis resistance by p38 MAPK in hypericin-mediated photodynamic therapy of human cancer cells
J Biol Chem
Photodynamic therapy in oncology
Oncologist
Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma; results of a multicenter randomized prospective trial
Arch Dermatol
Photodynamic therapy in dermatology: current treatments and implications
Coll Antropol
Photophysics and photochemistry of melanin
Indocyanine green as a prospective sensitizer for photodynamic therapy of melanomas
Acta Biochim Pol
Cancer chemopreventive activity of odorine and odorinol from Aglaia odorata
Biol Pharm Bull
Cutaneous two-stage chemical carcinogenesis
CSH Protoc.
Ischemic skin wound healing models in rats
Wounds
Cited by (10)
The role of FOS-mediated autophagy activation in the indocyanine green-based photodynamic therapy for treating melanoma
2021, Journal of Photochemistry and Photobiology B: BiologyCitation Excerpt :So as to clinical effect guarantee, local temperature was monitored and controlled in real time using infrared thermometers [9]. During this process, ICG acted as a near infrared (NIR) photosensitizer and generated heat and ROS forthwith through radiation with relative fine efficacy compared with current photosensitizers [10–12]. However, in research respect, the further investigations of treatment mechanisms are needed.
α-Mangostin inhibits DMBA/TPA-induced skin cancer through inhibiting inflammation and promoting autophagy and apoptosis by regulating PI3K/Akt/mTOR signaling pathway in mice
2017, Biomedicine and PharmacotherapyCitation Excerpt :Therefore, naturally derived non-toxic compounds have been searched to treat skin cancer in recent years. Inflammatory responses play a crucial role in regulating a wide range of cells involved in initiation [8], promotion [9,10], malignant transformation, invasion [11], metastasis and multistage carcinogenesis [12,13]. Accumulating evidence has linked the improvement of inflammatory microenvironment to tumor reversal [14–16].
Photodynamic therapy activated STAT3 associated pathways: Targeting intrinsic apoptotic pathways to increase PDT efficacy in human squamous carcinoma cells
2016, Photodiagnosis and Photodynamic TherapyCitation Excerpt :In trials, the appearance of the treated area after PDT is better than after surgery. PDT has become a key treatment for skin cancers, an established and growing health issue in many regions of the world [36]. It is now known that there are three main mechanisms by which PDT mediates tumor destruction: (1) direct kill tumor cells through ROS that is generated by PDT, (2) damage to the vasculature, and (3) rapid recruitment and activation of immune cells that activate an immune response against tumor cells [37].
Viscosity Effects on Excited-State Dynamics of Indocyanine Green for Phototheranostic
2022, Chemistry - An Asian Journal